Literature DB >> 6100843

Inhibition by xanthine derivatives of adenosine receptor-stimulated cyclic adenosine 3',5'-monophosphate accumulation in rat and guinea-pig thymocytes.

B B Fredholm, G Sandberg.   

Abstract

The effect of stable adenosine analogues, including adenosine 5'-N-ethylcarboxamide (NECA) and N6-L-phenylisopropyl-adenosine (L-PIA), were studied on cyclic adenosine 3', 5'-monophosphate (cyclic AMP) accumulation in rat and guinea-pig thymocytes. NECA was approximately 10 times more potent than L-PIA, in thymocytes from both species. D-PIA was more potent in guinea-pig than in rat thymocytes. The effect of a number of adenosine analogues followed the order: NECA greater than 2-chloro-adenosine greater than L-PIA greater than N6-cyclohexyl-adenosine (CHA), an order of potency characteristic for adenosine receptors of the A2-subtype. Thymocytes may be used as a model system to study the pharmacology of such receptors. Several xanthines were studied as antagonists of the NECA (1 microM)-induced cyclic AMP accumulation. The order of potency was: 1,3-diethyl-8-phenylxanthine greater than 8-phenyl-theophylline greater than IBMX = 8-p-sulphophenyltheophylline = verrophylline greater than theophylline greater than caffeine greater than enprofylline greater than theobromine greater than pentoxiphylline. The pA2 value for 8-phenyltheophylline was 0.35 microM, and the antagonism was shown to be competitive. The order of potency of the xanthine is virtually identical to that found earlier in several other systems in which the receptors are of the A1-subtype. None of the xanthine derivatives tested thus seem to discriminate between A1 and A2-receptor-mediated adenosine actions.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6100843      PMCID: PMC2045063          DOI: 10.1111/j.1476-5381.1983.tb10053.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  24 in total

1.  Characterization of adenosine receptors in rat brain by (-)[3H]N6-phenylisopropyladenosine.

Authors:  U Schwabe; T Trost
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1980-09       Impact factor: 3.000

2.  How to analyze binding, enzyme and uptake data: the simplest case, a single phase.

Authors:  J A Zivin; D R Waud
Journal:  Life Sci       Date:  1982-04-26       Impact factor: 5.037

3.  Subclasses of external adenosine receptors.

Authors:  C Londos; D M Cooper; J Wolff
Journal:  Proc Natl Acad Sci U S A       Date:  1980-05       Impact factor: 11.205

4.  Adenosine antagonism, a less desirable characteristic of xanthine asthma drugs?

Authors:  C G Persson; I Erjefält; J A Karlsson
Journal:  Acta Pharmacol Toxicol (Copenh)       Date:  1981-10

5.  Adenosine receptors mediating cyclic AMP production in the rat hippocampus.

Authors:  B B Fredholm; B Jonzon; E Lindgren; K Lindström
Journal:  J Neurochem       Date:  1982-07       Impact factor: 5.372

6.  Adenosine receptors in brain membranes: binding of N6-cyclohexyl[3H]adenosine and 1,3-diethyl-8-[3H]phenylxanthine.

Authors:  R F Bruns; J W Daly; S H Snyder
Journal:  Proc Natl Acad Sci U S A       Date:  1980-09       Impact factor: 11.205

7.  Xanthine derivatives as adenosine receptor antagonists.

Authors:  B B Fredholm; C G Persson
Journal:  Eur J Pharmacol       Date:  1982-07-30       Impact factor: 4.432

8.  Regulation of thymocyte proliferation: effects of L-alanine, adenosine and cyclic AMP in vitro.

Authors:  G Sandberg; B B Fredholm
Journal:  Thymus       Date:  1981-08

9.  Metabolic basis for disorders of purine nucleotide degradation.

Authors:  I H Fox
Journal:  Metabolism       Date:  1981-06       Impact factor: 8.694

View more
  8 in total

1.  Functional characterization of adenosine A2 receptors in Jurkat cells and PC12 cells using adenosine receptor agonists.

Authors:  I van der Ploeg; S Ahlberg; F E Parkinson; R A Olsson; B B Fredholm
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1996-02       Impact factor: 3.000

2.  The adenosine receptor activity of EMD 28422, a purine derivative with reported actions on benzodiazepine receptors.

Authors:  T V Dunwiddie; B B Fredholm; B Jonzon; G Sandberg
Journal:  Br J Pharmacol       Date:  1985-03       Impact factor: 8.739

3.  Functional evidence for the presence of adenosine A2-receptors in cultured coronary endothelial cells.

Authors:  C Des Rosiers; S Nees
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1987-07       Impact factor: 3.000

4.  Pentoxifylline downregulates profibrogenic cytokines and procollagen I expression in rat secondary biliary fibrosis.

Authors:  C Raetsch; J D Jia; G Boigk; M Bauer; E G Hahn; E-O Riecken; D Schuppan
Journal:  Gut       Date:  2002-02       Impact factor: 23.059

5.  Effect of adenosine receptor agonists and other compounds on cyclic AMP accumulation in forskolin-treated hippocampal slices.

Authors:  B B Fredholm; B Jonzon; K Lindström
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1986-02       Impact factor: 3.000

6.  The activation of P1- and P2-purinoceptors in the guinea-pig left atrium by diadenosine polyphosphates.

Authors:  C H Hoyle; A U Ziganshin; J Pintor; G Burnstock
Journal:  Br J Pharmacol       Date:  1996-07       Impact factor: 8.739

Review 7.  Purinergic signalling in endocrine organs.

Authors:  Geoffrey Burnstock
Journal:  Purinergic Signal       Date:  2013-11-22       Impact factor: 3.765

Review 8.  Purinergic signalling and immune cells.

Authors:  Geoffrey Burnstock; Jean-Marie Boeynaems
Journal:  Purinergic Signal       Date:  2014-10-29       Impact factor: 3.765

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.